title: Retraction. Targeting neural-restrictive silencer factor sensitizes tumor cells to antibody-based cancer immunotherapy in vitro via multiple mechanisms.
authors.affiliation: School of Medicine Cardiff University Cardiff, United Kingdom.
authors.forename: Martin V
authors.initials: MV
authors.lastname: Kolev
authors.forename: B Paul
authors.initials: BP
authors.lastname: Morgan
authors.forename: Marieta M
authors.initials: MM
authors.lastname: Ruseva
authors.forename: Rossen M
authors.initials: RM
authors.lastname: Donev